Bio-Techne TECH EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from Bio-Techne’s reported figures.
Based on trailing twelve months.
The official record: Bio-Techne’s 10-Q, filed May 8, 2025, on SEC EDGAR. View the filing →
Ask your AI about Bio-Techne's ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Techne's EBITDA margin?
- Bio-Techne (TECH) reported EBITDA margin of 23.4% in Q1 2025.
- How has Bio-Techne's EBITDA margin changed year-over-year?
- Bio-Techne's EBITDA margin decreased by 26.2% year-over-year, from 31.7% to 23.4%.
- What is the long-term trend for Bio-Techne's EBITDA margin?
- Over 2 years (2022 to 2024), Bio-Techne's EBITDA margin has grown at a -12.6% compound annual growth rate (CAGR), from 36% to 27.5%.
- What does EBITDA margin mean?
- Operating cash profitability per sales dollar, before interest, taxes, and non-cash charges.
- How do you interpret EBITDA margin?
- Useful for comparing operating profitability across firms with different depreciation policies and leverage. High EBITDA margin alongside heavy capex can still mean weak free cash flow — pair it with FCF margin.
- How does EBITDA margin compare across companies?
- Widely used to compare capital-intensive businesses on a like-for-like basis. Less meaningful for banks and insurers.